Fred Alger Management Trimmed Its Holding in Bluebird Bio (BLUE) by $2.09 Million as Share Price Rose; Covanta Holding (CVA) Shareholder Thompson Siegel & Walmsley Has Cut Its Holding by $4.86 Million as Shares Rose

Covanta Holding Corporation (NYSE:CVA) Logo

Fred Alger Management Inc decreased its stake in Bluebird Bio Inc (BLUE) by 39.7% based on its latest 2018Q4 regulatory filing with the SEC. Fred Alger Management Inc sold 21,074 shares as the company’s stock rose 25.54% with the market. The institutional investor held 32,011 shares of the health care company at the end of 2018Q4, valued at $3.18 million, down from 53,085 at the end of the previous reported quarter. Fred Alger Management Inc who had been investing in Bluebird Bio Inc for a number of months, seems to be less bullish one the $8.68 billion market cap company. The stock increased 4.27% or $6.47 during the last trading session, reaching $158.04. About 441,620 shares traded. bluebird bio, Inc. (NASDAQ:BLUE) has declined 24.77% since March 17, 2018 and is downtrending. It has underperformed by 29.14% the S&P500. Some Historical BLUE News: 17/04/2018 – Poseida Announces Initial Phase 1 Data for P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma; 23/05/2018 – Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell &; 29/03/2018 – Neuberger Berman Mid Cap Growth Adds Bluebird Bio; 23/05/2018 – BLUEBIRD BIO: FDA GRANTS BREAKTHROUGH DESIGNATION TO LENTI-D; 08/05/2018 – UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing; 11/05/2018 – Bluebird Bio Closes Above 50-Day Moving Average: Technicals; 19/04/2018 – CELLULAR BIOMEDICINE: CHINA FDA ACCEPTS CAR-T IND APPLICATION; 03/04/2018 – They built a game-changing cancer-killing therapy. Now they’re taking on a new kind of CAR-T therapy; 27/04/2018 – CELYAD SA CYAD.BR – DEMONSTRATED 1ST OBJECTIVE RESPONSE TO ANY CAR-T IN RELAPSED/REFRACTORY AML WITHOUT PRECONDITIONING CHEMOTHERAPY HIGHLIGHTS POTENTIAL OF CYAD-01 AS TREATMENT FOR AML; 08/05/2018 – Bluebird Bio at Deutsche Bank Health Care Conference Tomorrow

Thompson Siegel & Walmsley Llc decreased its stake in Covanta Holding Corp (CVA) by 85.02% based on its latest 2018Q4 regulatory filing with the SEC. Thompson Siegel & Walmsley Llc sold 373,523 shares as the company’s stock rose 2.02% with the market. The institutional investor held 65,814 shares of the central company at the end of 2018Q4, valued at $883,000, down from 439,337 at the end of the previous reported quarter. Thompson Siegel & Walmsley Llc who had been investing in Covanta Holding Corp for a number of months, seems to be less bullish one the $2.23B market cap company. The stock increased 0.06% or $0.01 during the last trading session, reaching $17.09. About 935,328 shares traded or 14.27% up from the average. Covanta Holding Corporation (NYSE:CVA) has risen 11.13% since March 17, 2018 and is uptrending. It has outperformed by 6.76% the S&P500. Some Historical CVA News: 15/03/2018 – COVANTA HOLDING CORP CVA.N : CREDIT SUISSE ASSUMES COVERAGE WITH NEUTRAL RATING AND TARGET PRICE OF $16; 26/04/2018 – Covanta Holding 1Q Rev $458M; 26/04/2018 – Covanta Holding Sees 2018 Adjusted Ebitda $425M-$455M; 18/04/2018 – Covanta Environmental Solutions to Provide Collection Kiosks and Secure Disposal for New York State’s Pilot Pharmaceutical Take; 09/05/2018 – Covanta Appoints Ginny Angilello as Chief Human Resources Officer; 05/03/2018 Covanta Holding Closes Above 200-Day Moving Average: Technicals; 17/05/2018 – Covanta Holding Presenting at Conference Jun 13; 26/04/2018 – COVANTA HOLDING CORP CVA.N – AFFIRMING 2018 GUIDANCE; 26/04/2018 – Covanta Holding 1Q EPS $1.53; 26/04/2018 – Covanta Holding Corp Reports 2018 1Q Results and Affirms 2018 Guidance

Analysts await Covanta Holding Corporation (NYSE:CVA) to report earnings on April, 25. They expect $-0.13 EPS, down 44.44% or $0.04 from last year’s $-0.09 per share. After $0.04 actual EPS reported by Covanta Holding Corporation for the previous quarter, Wall Street now forecasts -425.00% negative EPS growth.

Thompson Siegel & Walmsley Llc, which manages about $7.40B and $6.40B US Long portfolio, upped its stake in Nielsen Hldgs Plc by 905,713 shares to 2.85M shares, valued at $66.60 million in 2018Q4, according to the filing. It also increased its holding in Mohawk Industries Inc (NYSE:MHK) by 158,149 shares in the quarter, for a total of 414,163 shares, and has risen its stake in Boot Barn Hldgs Inc (NYSE:BOOT).

More notable recent Covanta Holding Corporation (NYSE:CVA) news were published by: Seekingalpha.com which released: “Key Takeaways From Covanta’s Earnings Call – Seeking Alpha” on April 30, 2018, also Businesswire.com with their article: “Cascade Virtual Academy Invites Students to Enroll for 2019-20 School Year – Business Wire” published on February 28, 2019, Seekingalpha.com published: “Covanta: Anything But A Waste (Of Time) – Seeking Alpha” on July 30, 2018. More interesting news about Covanta Holding Corporation (NYSE:CVA) were released by: Seekingalpha.com and their article: “Covanta Q4 2018 Earnings Preview – Seeking Alpha” published on February 13, 2019 as well as Seekingalpha.com‘s news article titled: “Covanta Holding Corporation’s (CVA) CEO Steve Jones on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: February 15, 2019.

More notable recent bluebird bio, Inc. (NASDAQ:BLUE) news were published by: Nasdaq.com which released: “Ferrellgas (FGP) Expands Blue Rhino Business Via Acquisition – Nasdaq” on March 04, 2019, also Nasdaq.com with their article: “Abu Dhabi and Qatar drop as heavyweight blue-chips go ex-dividend – Nasdaq” published on March 06, 2019, Nasdaq.com published: “Dow Overcomes a Technical Barrier After 3 Months: 4 Top Picks – Nasdaq” on February 26, 2019. More interesting news about bluebird bio, Inc. (NASDAQ:BLUE) were released by: Nasdaq.com and their article: “FTSE 100 down as M&S slumps on Ocado deal rights issue – Nasdaq” published on February 27, 2019 as well as Nasdaq.com‘s news article titled: “Trade of the Day: Facebook Stock Is a Breakout Play – Nasdaq” with publication date: March 06, 2019.

Investors sentiment decreased to 0.94 in Q4 2018. Its down 0.20, from 1.14 in 2018Q3. It turned negative, as 52 investors sold BLUE shares while 65 reduced holdings. 38 funds opened positions while 72 raised stakes. 59.32 million shares or 5.58% more from 56.18 million shares in 2018Q3 were reported. Bnp Paribas Asset Management Holdings Sa holds 0.05% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE) for 58,684 shares. Eventide Asset Mgmt Lc reported 1.22% in bluebird bio, Inc. (NASDAQ:BLUE). First Advsr Ltd Partnership has invested 0.18% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE). Cap Ww Investors reported 3.71M shares. Mckinley Mgmt Delaware holds 0.01% or 932 shares in its portfolio. Financial Bank Of Mellon Corp owns 225,455 shares or 0.01% of their US portfolio. Next Fincl Grp Inc holds 0% or 16 shares. 2,585 were accumulated by Qvt Fincl Limited Partnership. Pnc Serv Grp accumulated 756 shares. Rmb Cap Mngmt Ltd Liability Company reported 0.04% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE). Stanley accumulated 2,022 shares. Kbc Nv owns 18,235 shares or 0.02% of their US portfolio. Bokf Na reported 830 shares. Comerica National Bank reported 1,917 shares stake. First Hawaiian Fincl Bank invested in 0% or 62 shares.

Analysts await bluebird bio, Inc. (NASDAQ:BLUE) to report earnings on May, 1. They expect $-2.81 earnings per share, down 21.65% or $0.50 from last year’s $-2.31 per share. After $-2.72 actual earnings per share reported by bluebird bio, Inc. for the previous quarter, Wall Street now forecasts 3.31% negative EPS growth.

Fred Alger Management Inc, which manages about $21.12B and $21.72 billion US Long portfolio, upped its stake in Canada Goose Holdings Inc by 356,218 shares to 1.64M shares, valued at $71.50 million in 2018Q4, according to the filing. It also increased its holding in Burlington Stores Inc (NYSE:BURL) by 35,541 shares in the quarter, for a total of 217,489 shares, and has risen its stake in Nike Inc Cl B (NYSE:NKE).

bluebird bio, Inc. (NASDAQ:BLUE) Ratings Chart